Skip to content
Generic filters
Exact matches only
Search in title
Search in content
Search in excerpt
Filter by Article Type
Papers
Events
Tools
Funding Articles
Case Studies
Resources
Opportunities
Theme Editor Blogs
Filter by Categories
Business model innovation
Ideation and creativity in R&D
Latest news
Managing international R&D
Managing technology platforms
Managing the R&D pipeline
Open innovation
Outsourcing R&D
Project valuation and selection
R&D strategy
Roadmapping
Stage gate processes
Technology intelligence
  • Home
  • About
    • About R&D Today
    • Contributors
    • R&D Publications
    • R&D Today newsletter archive
  • Themes
    • R&D Management
      • Rationale for key themes
      • Ideation and creativity in R&D
      • Managing international R&D
      • Managing the R&D pipeline
      • Open Innovation
      • Roadmapping
      • Technology Strategy
    • Special Features
      • Innovation for a Sustainable Future
      • How to measure the value created by innovation
      • Dynamic capabilities for strategic innovation
      • Would a ‘Strategy Lab’ provide sustainable renewal of competitive advantage?
      • Design Thinking
      • China’s new model for Open Innovation
      • Penetrating the fog of Agile
      • The resurgence of frugal innovation
      • Impact of digital technologies
    • Key Conference Tracks
      • Business model innovation
      • Entrepreneurial Ecosystems, Innovation Ecosystems and platforms
      • Intellectual Property Rights
      • Sustainable Innovation
    • Innovation Leadership
  • RADMA
    • About RADMA
    • R&D Project Exchange
    • Celebrating 40 Years of RADMA
    • RADMA Scholars
    • R&D Management Journal
  • The Pentathlon Framework
    • Strategy
    • Ideas
    • Selection & Prioritisation
    • Implementation
    • People & Organisations
  • Knowledge Hub
  • R&D Management Conference
  • Events
    • Upcoming events
    • Events Archive
  • Contact
  • Home
  • About
    • About R&D Today
    • Contributors
    • R&D Publications
    • R&D Today newsletter archive
  • Themes
    • R&D Management
      • Rationale for key themes
      • Ideation and creativity in R&D
      • Managing international R&D
      • Managing the R&D pipeline
      • Open Innovation
      • Roadmapping
      • Technology Strategy
    • Special Features
      • Innovation for a Sustainable Future
      • How to measure the value created by innovation
      • Dynamic capabilities for strategic innovation
      • Would a ‘Strategy Lab’ provide sustainable renewal of competitive advantage?
      • Design Thinking
      • China’s new model for Open Innovation
      • Penetrating the fog of Agile
      • The resurgence of frugal innovation
      • Impact of digital technologies
    • Key Conference Tracks
      • Business model innovation
      • Entrepreneurial Ecosystems, Innovation Ecosystems and platforms
      • Intellectual Property Rights
      • Sustainable Innovation
    • Innovation Leadership
  • RADMA
    • About RADMA
    • R&D Project Exchange
    • Celebrating 40 Years of RADMA
    • RADMA Scholars
    • R&D Management Journal
  • The Pentathlon Framework
    • Strategy
    • Ideas
    • Selection & Prioritisation
    • Implementation
    • People & Organisations
  • Knowledge Hub
  • R&D Management Conference
  • Events
    • Upcoming events
    • Events Archive
  • Contact

Menu

Pasteur’s Quadrant: a wonderful example of KISS*?

I recently came across Donald E. Stokes’ book: “Pasteur’s Quadrant: Basic Science and Technological Innovation”. I had just started a new role in industry as “Science & Technology Lead” and the book turned out to be very helpful. My role was loosely defined, but one key part went along the lines of “get the great scientists we have in our business doing the things that add most value”.

What are our scientists doing?

One of the first things I had to do was to step back and get an understanding of what our great scientists were actually doing.

When I talk about “great scientists” here the individuals I refer to are a group of approximately 50 world leaders in their fields who have chosen to come and work in Pharmaceutical R&D. These are individuals with choices: if they weren’t working with us they could be working in academia, which would be a shame or with our competitors which would be unfortunate!

These are creative people who if given space, time and freedom do great things. The challenge in an R&D intensive business like big pharma is that these things ultimately need to return value if we are to have a sustainable model.

I spent many hours talking and, more importantly, listening to these scientists as they shared with me the range of things they were doing. It was mind-blowing, intimidating even, as the range of scientific specialisms in our department is vast.

Research at AstraZeneca includes:

  • understanding of biological systems and cellular transport,
  • advanced physics behind the analytical characterization of complex drugs
  • chemistry required to synthesis new drugs
  • modelling and prediction of drug behaviour in the gut
  • engineering challenges associated with developing industrial manufacturing processes that could produce billions of tablets per year.

There was no end of activity. All of it was worthy and challenging.

Some of the work was very clearly applied in its nature, some of it was more fundamental research but any attempt to categorise activities into two simple types: “basic” and “applied” just did not work.

It was at this point that I came across “Pasteur’s Quadrant”.

Quadrant Model of Scientific Research (Stokes’ Model)
Quadrant Model of Scientific Research (Stokes’ Model)

The book by Donald E.Stokes describes how a simple framework that attempts to describe research as “basic” or “applied” is too simplistic. “Basic Research” for me is about the quest for fundamental understanding or the search for truth whereas “Applied Research” is about consideration of use and application.

Stokes’ book introduces the concept of “use inspired basic research” and presents a simple fourfold table:

A use inspired definition of research

Stokes goes on to describe Bohr’s quest for the fundamental understanding of atomic structure as being all about basic scientific curiosity and the search for truth with little idea about the potential utility of the work. Hence this work by Bohr is categorized as “Pure Basic Research”.

On the other hand Edison’s work in Menlo Park at what Stokes describes as America’s “first industrial research laboratory” was solely focused on the ambition to create commercially profitable electric lighting. Edison’s work is categorized as “Pure Applied Research”. Here the focus is very narrowly targeted on immediate applied goals.

Pasteur’s work always had application in mind yet provided fundamental contributions to science that are key foundations that underpin the whole field of microbiology. Pasteur successfully brought together scientific curiosity and creativity and his work is used as the exemplar of “Use-Inspired Basic Research”.

The fourth quadrant, though blank in the figure, does truly exist and Stokes provides some examples in his book that I will leave you to explore.

Applying the model

Back to the start of this story…with this simple yet powerful framework in mind I made rapid progress with assimilating the work that our “great scientists” were doing. However where the real benefit came was in reflecting the concept of Pasteur’s Quadrant back to the scientists themselves and asking them to consider where their work fitted into Stokes’ model.

Pasteur's Quadrant
Pasteur’s Quadrant

There is no right nor wrong in all of this but Pasteur’s Quadrant and the concept of “Use-Inspired Basic Research” is a valuable but simple tool for bringing together the, at times, contradictory concepts of basic and applied research in a complementary and harmonious way and making a little more sense of the true complexity of R&D.

Donald E. Stokes: “Pasteur’s Quadrant: Basic Science and Technological Innovation”.
The Brookings Institute Press. 1997

Dr Joe de Sousa
Director Science & Technology
Global Product Development
AstraZeneca, Macclesfield, UK

*KISS – “Keep It Simple Stupid”

  • 11 May 2017
View our newsletter archive
  • Related posts

    • Using the game ‘Top Trumps’ as a communications tool
    • Learning from the past: portfolio management in pharma R&D
    • Portfolio Visualisation: Making it easy, being transparent, making better decisions
    • R&D Management Conference
    • Creativity, roadmapping, devising technology strategies: key R&D issues
    • R&D Management Conference highlights for practitioners
  • Have your say

    Have your say / Follow us

    Linkedin Soundcloud Twitter Youtube Linkedin-in

    R&D Today is the outreach site for the Research and Development Management Association, a charitable organisation that supports research, best practice and innovation.  www.radma.net

    Click here to sign up to our newsletter, and
     click here to view our newsletter archive.

    © Copyright R&D Today

    2025.

    All rights reserved.